206 related articles for article (PubMed ID: 14501830)
1. An economic viewpoint on alternative strategies for identifying persons with hereditary nonpolyposis colorectal cancer.
Ramsey SD; Burke W; Clarke L
Genet Med; 2003; 5(5):353-63. PubMed ID: 14501830
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer.
Piñol V; Castells A; Andreu M; Castellví-Bel S; Alenda C; Llor X; Xicola RM; Rodríguez-Moranta F; Payá A; Jover R; Bessa X;
JAMA; 2005 Apr; 293(16):1986-94. PubMed ID: 15855432
[TBL] [Abstract][Full Text] [Related]
3. Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma: effectiveness and cost-effectiveness.
Reyes CM; Allen BA; Terdiman JP; Wilson LS
Cancer; 2002 Nov; 95(9):1848-56. PubMed ID: 12404277
[TBL] [Abstract][Full Text] [Related]
4. Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening.
Julié C; Trésallet C; Brouquet A; Vallot C; Zimmermann U; Mitry E; Radvanyi F; Rouleau E; Lidereau R; Coulet F; Olschwang S; Frébourg T; Rougier P; Nordlinger B; Laurent-Puig P; Penna C; Boileau C; Franc B; Muti C; Hofmann-Radvanyi H
Am J Gastroenterol; 2008 Nov; 103(11):2825-35; quiz 2836. PubMed ID: 18759827
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer.
Ramsey SD; Clarke L; Etzioni R; Higashi M; Berry K; Urban N
Ann Intern Med; 2001 Oct; 135(8 Pt 1):577-88. PubMed ID: 11601929
[TBL] [Abstract][Full Text] [Related]
6. Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing.
Terdiman JP; Gum JR; Conrad PG; Miller GA; Weinberg V; Crawley SC; Levin TR; Reeves C; Schmitt A; Hepburn M; Sleisenger MH; Kim YS
Gastroenterology; 2001 Jan; 120(1):21-30. PubMed ID: 11208710
[TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness of a new strategy to identify HNPCC patients.
Kievit W; de Bruin JH; Adang EM; Severens JL; Kleibeuker JH; Sijmons RH; Ruers TJ; Nagengast FM; Vasen HF; van Krieken JH; Ligtenberg MJ; Hoogerbrugge N
Gut; 2005 Jan; 54(1):97-102. PubMed ID: 15591512
[TBL] [Abstract][Full Text] [Related]
8. Microsatellite instability analysis in hereditary non-polyposis colon cancer using the Bethesda consensus panel of microsatellite markers in the absence of proband normal tissue.
Chialina SG; Fornes C; Landi C; de la Vega Elena CD; Nicolorich MV; Dourisboure RJ; Solano A; Solis EA
BMC Med Genet; 2006 Jan; 7():5. PubMed ID: 16426447
[TBL] [Abstract][Full Text] [Related]
9. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).
Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Nakagawa H; Sotamaa K; Prior TW; Westman J; Panescu J; Fix D; Lockman J; Comeras I; de la Chapelle A
N Engl J Med; 2005 May; 352(18):1851-60. PubMed ID: 15872200
[TBL] [Abstract][Full Text] [Related]
10. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
[TBL] [Abstract][Full Text] [Related]
11. The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer.
Mvundura M; Grosse SD; Hampel H; Palomaki GE
Genet Med; 2010 Feb; 12(2):93-104. PubMed ID: 20084010
[TBL] [Abstract][Full Text] [Related]
12. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.
Umar A; Boland CR; Terdiman JP; Syngal S; de la Chapelle A; Rüschoff J; Fishel R; Lindor NM; Burgart LJ; Hamelin R; Hamilton SR; Hiatt RA; Jass J; Lindblom A; Lynch HT; Peltomaki P; Ramsey SD; Rodriguez-Bigas MA; Vasen HF; Hawk ET; Barrett JC; Freedman AN; Srivastava S
J Natl Cancer Inst; 2004 Feb; 96(4):261-8. PubMed ID: 14970275
[TBL] [Abstract][Full Text] [Related]
13. Molecular screening for the Lynch syndrome--better than family history?
Lynch HT; Lynch PM
N Engl J Med; 2005 May; 352(18):1920-2. PubMed ID: 15872208
[No Abstract] [Full Text] [Related]
14. Correlations between phenotype and microsatellite instability in HNPCC: implications for genetic testing.
Palmirotta R; Matera S; Curia MC; Aceto G; el Zhobi B; Verginelli F; Guadagni F; Casale V; Stigliano V; Messerini L; Mariani-Costantini R; Battista P; Cama A
Fam Cancer; 2004; 3(2):117-21. PubMed ID: 15340262
[TBL] [Abstract][Full Text] [Related]
15. Genetic testing for hereditary nonpolyposis colorectal cancer.
Hoedema R; Monroe T; Bos C; Palmer S; Kim D; Marvin M; Luchtefeld M
Am Surg; 2003 May; 69(5):387-91; discussion 391-2. PubMed ID: 12769209
[TBL] [Abstract][Full Text] [Related]
16. BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing.
Domingo E; Laiho P; Ollikainen M; Pinto M; Wang L; French AJ; Westra J; Frebourg T; Espín E; Armengol M; Hamelin R; Yamamoto H; Hofstra RM; Seruca R; Lindblom A; Peltomäki P; Thibodeau SN; Aaltonen LA; Schwartz S
J Med Genet; 2004 Sep; 41(9):664-8. PubMed ID: 15342696
[TBL] [Abstract][Full Text] [Related]
17. Novel strategy for optimal sequential application of clinical criteria, immunohistochemistry and microsatellite analysis in the diagnosis of hereditary nonpolyposis colorectal cancer.
Engel C; Forberg J; Holinski-Feder E; Pagenstecher C; Plaschke J; Kloor M; Poremba C; Pox CP; Rüschoff J; Keller G; Dietmaier W; Rümmele P; Friedrichs N; Mangold E; Buettner R; Schackert HK; Kienle P; Stemmler S; Moeslein G; Loeffler M;
Int J Cancer; 2006 Jan; 118(1):115-22. PubMed ID: 16003745
[TBL] [Abstract][Full Text] [Related]
18. Identification of HNPCC by molecular analysis of colorectal and endometrial tumors.
Vasen HF; Hendriks Y; de Jong AE; van Puijenbroek M; Tops C; Bröcker-Vriends AH; Wijnen JT; Morreau H
Dis Markers; 2004; 20(4-5):207-13. PubMed ID: 15528786
[TBL] [Abstract][Full Text] [Related]
19. Early-age-at-onset colorectal cancer and microsatellite instability as markers of hereditary nonpolyposis colorectal cancer.
Pucciarelli S; Agostini M; Viel A; Bertorelle R; Russo V; Toppan P; Lise M
Dis Colon Rectum; 2003 Mar; 46(3):305-12. PubMed ID: 12626904
[TBL] [Abstract][Full Text] [Related]
20. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
